Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Drug Safety

• Publication date

  2017-06-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40264-017-0561-yPMID 28664354
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacovigilance - The next chapter.

  2019cited by this paper
• Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

  2016influential reference
• Consequences of dextropropoxyphene market withdrawal in elderly patients with chronic pain

  2014influential reference
• ["Serious" adverse drug reactions with tramadol: a 2010-2011 pharmacovigilance survey in France].

  2013cited by this paper
• Effets indésirables « graves » du tramadol : bilan 2010-2011 de pharmacovigilance en France

  2013cited by this paper
• Is spontaneous reporting always the most important information supporting drug withdrawals for pharmacovigilance reasons in France?

  2012cited by this paper
• Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study

  2012cited by this paper
• [Which analgesic after dextropropoxyphene withdrawal? A survey in a sample of general practitioners in southwest of France].

  2011cited by this paper
• Quel(s) antalgique(s) après le retrait du dextropropoxyphène ? Enquête auprès de médecins généralistes de la région Midi-Pyrénées

  2011cited by this paper
• French national health insurance information system and the permanent beneficiaries sample.

  2010cited by this paper
• Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: a retrospective study of physician-patient pairs in Taiwan.

  2009influential reference
• NSAID switching and short‐term gastrointestinal outcome rates after the withdrawal of rofecoxib

  2009influential reference
• L'échantillon généraliste de bénéficiaires : représentativité, portée et limites

  2009cited by this paper
• Impact of Safety Alerts on Measures of Disproportionality in Spontaneous Reporting Databases The Notoriety Bias

  2007cited by this paper
• Under-Reporting of Adverse Drug Reactions

  2006cited by this paper
• Statin safety: an appraisal from the adverse event reporting system.

  2006influential reference
• Joining the DoTS: new approach to classifying adverse drug reactions

  2003cited by this paper
• The Medical Dictionary for Regulatory Activities (MedDRA)

  1999cited by this paper
• [French pharmacovigilance database system: examples of utilisation].

  1995cited by this paper
• La consommation des benzodiazépines en France

  1991cited by this paper
• Under-reporting of adverse drug reactions.

  1985cited by this paper
• Adverse drug reaction monitoring: doing it the French way.

  1985cited by this paper

• Pharmacovigilance and Appropriate Drug Use

  2024cites this paper
• Unintended impact of pharmacovigilance regulatory interventions: A systematic review

  2023cites this paper
• Analgesic switching in chronic users of dextropropoxyphene in France

  2023cites this paper
• Chinese-Named Entity Recognition From Adverse Drug Event Records: Radical Embedding-Combined Dynamic Embedding–Based BERT in a Bidirectional Long Short-term Conditional Random Field (Bi-LSTM-CRF) Model

  2020cites this paper
• Named entity recognition from Chinese adverse drug event reports with lexical feature based BiLSTM-CRF and tri-training

  2019cites this paper
• Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety

  2018cites this paper
• Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients

  2017cites this paper
• Développement d’un système automatisé de détection et de priorisation des signaux de sécurité adapté aux bases de données médico-administratives

  2017cites this paper